Accelerating Discovery of Leukemia Inhibitors Using AI-Driven Quantitative Structure-Activity Relationship: Algorithm Development and Validation

Integrating advanced ML with QSAR modeling enables systematic analysis of structure-activity relationships in thiadiazolidinone analogs on this dataset. While ensemble methods capture complex patterns with high internal validation metrics, external validation on independent compounds and prospective experimental testing are essential before broad therapeutic claims can be made. This work provides a methodological foundation and identifies molecular features for future validation efforts.

Authors

Institutions

Publication Details

Journal
JMIR AI
Published
2025-12-05
DOI
https://doi.org/10.2196/81552
Citations
2
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
3.01
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Accelerating Discovery of Leukemia Inhibitors Using AI-Driven Quantitative Structure-Activity Relationship: Algorithm Development and Validation

Robert J. Shmookler Reis, Samuel Kakraba, Edmund Fosu Agyemang
2 citations
JMIR AI
Computational Drug Discovery Methods
3.01
article

Accelerating Discovery of Leukemia Inhibitors Using AI-Driven Quantitative Structure-Activity Relationship: Algorithm Development and Validation

Robert J. Shmookler Reis, Samuel Kakraba, Edmund Fosu Agyemang
article en
2 citations

Abstract

Integrating advanced ML with QSAR modeling enables systematic analysis of structure-activity relationships in thiadiazolidinone analogs on this dataset. While ensemble methods capture complex patterns with high internal validation metrics, external validation on independent compounds and prospective experimental testing are essential before broad therapeutic claims can be made. This work provides a methodological foundation and identifies molecular features for future validation efforts.

JMIR AIVol. 5
Tulane University (US), University of Arkansas for Medical Sciences (US)
Openalex Percentile: Top 7%
Computational Drug Discovery Methods
3.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Accelerating Discovery of Leukemia Inhibitors Using AI-Driven Quantitative Structure-Activity Relationship: Algorithm Development and Validation — Robert J. Shmookler Reis, Samuel Kakraba, et al. · JMIR AI (2025) | TGRS Research Map | TGRS